Ana içeriğe geç
Dr Mohammed Almouzainy
Güven puanı 8/100

Dr Mohammed Almouzainy

Göğüs hastalıkları · AL Madinah AL Munawwarah

👤 2 yıllık deneyim

8,412+ Patients seen
2 Years in practice
4 Publications
2 Languages spoken

Hakkında

Dr Mohammed Almouzainy is a distinguished Consultant Clinical Pharmacist and healthcare leader based in Al Madinah Al Munawwarah, Saudi Arabia. He currently holds a senior position at the Women's, Maternity and Children's Hospital, where he plays a pivotal role in overseeing medical services and ensuring the highest standards of pharmaceutical care. His work focuses on optimizing medication therapy for vulnerable patient groups, including expectant mothers and children, ensuring that clinical protocols align with international safety standards.
With a robust academic foundation, Dr Almouzainy began his journey at the College of Pharmacy at King Saud University before pursuing advanced postgraduate studies in Clinical Pharmacy. His educational background has equipped him with the expertise to manage complex clinical cases and lead healthcare teams. He is deeply committed to the development of the pharmacy profession, advocating for the integration of clinical pharmacists into multidisciplinary medical teams to enhance patient outcomes.
In his professional capacity, Dr Almouzainy is recognised for his administrative leadership and his contributions to healthcare management. He has served as the Director of Medical Services, where he was responsible for coordinating departmental functions and implementing strategic health initiatives. His dedication extends to education and mentorship, where he actively supports the training of new practitioners and promotes best practices in medication safety and clinical efficacy within the region's healthcare system.

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Mohammed Almouzainy

Eğitim ve öğretim

  1. 2017–2023 MD · Medicine and Surgery
    UAB Barcelona, AL Madinah AL Munawwarah (SA)
  2. 2023–2027 Residency · Göğüs hastalıkları
    Universidad Complutense de Madrid, AL Madinah AL Munawwarah (SA)
  3. 2027–2028 Fellowship · Subspecialty training
    Royal Marsden London, UK

Kariyer ve atamalar

  1. 2027-09–2028-08 Junior consultant
    UAB Barcelona Teaching Hospital — Göğüs hastalıkları

Lisanslar ve sigorta

Tıbbi lisanslar

SA — Organización Médica Colegial de España (OMC)
#SA-708063 active · expires 2028-12-31

Kurul sertifikaları

European Board of Göğüs hastalıkları
#EB-ACDC97B6 · issued 2028 · renewal 2038
Mesleki sorumluluk sigortası: AXA Healthcare Liability · 3,000,000 EUR kapsam · No claims on file

Gerçekleştirilen prosedürler

ProsedürKodToplam sayı
GP consultation 99213 1,890
Annual physical exam 99395 2,820
Vaccination administration 90471 1,732
Minor procedure (skin) 17110 1,947

Hizmetler ve fiyatlandırma

HizmetSüreYöntemFiyat
New patient consultation (60m) 60 dk in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 dk in_clinic|telemed|phone 90.00 EUR
Vaccination administration 60 dk in_clinic 720.00 EUR
Minor procedure (skin) 90 dk in_clinic 630.00 EUR

Ofis, ekip ve uygulamada

Mohammed Almouzainy in consultation
IN OFFICE
Mohammed Almouzainy with the team
WITH TEAM
Mohammed Almouzainy at a conference
CONFERENCE

Videolar

introduction · 141s
Meet Mohammed Almouzainy

Araştırma ve yayınlar

h-endeksi: 5 · i10: 12

  1. Outcomes of Göğüs hastalıkları in adults — a multi-centre cohort
    Mohammed Almouzainy, et al. · European Journal of Medicine, 2025
    DOI: 10.7725/euroclin.2025.0 · PMID: 35412832 · alıntılayan 42
  2. European registry analysis of Göğüs hastalıkları outcomes
    Mohammed Almouzainy, et al. · European Journal of Medicine, 2024
    DOI: 10.6923/euroclin.2024.1 · PMID: 31308168 · alıntılayan 16
  3. Outcomes of Göğüs hastalıkları in adults — a multi-centre cohort
    Mohammed Almouzainy, et al. · European Journal of Medicine, 2023
    DOI: 10.5837/euroclin.2023.2 · PMID: 38558212 · alıntılayan 118
  4. European registry analysis of Göğüs hastalıkları outcomes
    Mohammed Almouzainy, et al. · European Journal of Medicine, 2022
    DOI: 10.8792/euroclin.2022.3 · PMID: 35840363 · alıntılayan 180

Davetli konuşmalar

  • Practical updates in Göğüs hastalıkları European Annual Congress (Göğüs hastalıkları) · Vienna · 2024 · invited
  • Single-centre experience in Göğüs hastalıkları National Society Meeting · AL Madinah AL Munawwarah · 2023 · oral abstract

Ödüller ve üyelikler

Ödüller

  • 🏆 Top-rated Göğüs hastalıkları — AL Madinah AL Munawwarah · EuroClinics Patient Choice · 2025 · regional

Topluluk üyelikleri

  • WONCA Europe — Family Doctors — Member · 2028 yılından beri
  • national college of family doctors — Member · 2028 yılından beri
  • European Union of Medical Specialists (UEMS) — Member · 2028 yılından beri

Bu doktorun makaleleri

  • Patient education Patient guide to Göğüs hastalıkları
  • Awareness When should you see a göğüs hastalıkları?

Uluslararası hastalar için

Koordinatör
Patient liaison · mohammed.almouzainy@euroclinics.example

Konum

1 etiket

Hasta yorumları

Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
20 – 4.000 karakter

Gönderiler moderasyondan geçer ve herkese açık olarak görünmesi 24-72 saat sürebilir. Hastayı tanımlayan bilgiler dahil edilmemelidir.

Son yorumlar

  • ★★★★★ ✓ Doğrulanmış
    Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
    Anna B.
  • ★★★★★ ✓ Doğrulanmış
    Took time to listen and reviewed all my previous results. I would absolutely recommend.
    Marco V.
  • ★★★★☆ ✓ Doğrulanmış
    Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
    Helena F.

Benzer uzmanlar

Tümünü gözat →